Hospitalizations of pregnant HIV-infected women in the United States in the era of highly active antiretroviral therapy (HAART)

Journal of Women's Health

Volumn 16, Issue 2, 2007, Pages 159-162

  Bansil, Pooja ^a   Jamieson, Denise J ^b   Posner, Samuel F ^b   Kourtis, Athena P ^b,c,d  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^d MS K34 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTEPARTUM HEMORRHAGE; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER DISEASE; MAJOR CLINICAL STUDY; MEDICAID; MEDICARE; MORBIDITY; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PRIORITY JOURNAL; SEPSIS; SEXUALLY TRANSMITTED DISEASE; STATISTICAL ANALYSIS; UNITED STATES; URBAN AREA; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BACTERIAL INFECTIONS; FEMALE; HIV INFECTIONS; HOSPITALIZATION; HUMANS; INSURANCE, HEALTH; MATERNAL WELFARE; MEDICAID; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PUERPERAL INFECTION; RISK FACTORS; UNITED STATES; WOMEN'S HEALTH;

EID: 34047203702     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2006.CDC2     Document Type: Article

References (10)

1. Fleming P, Lindegren ML, Byers RH, et al. Estimated number of perinatal HIV infections, United States, 2000. In: Program and abstracts of the XIV International Conference on AIDS, July 7-12, 2002, Barcelona, Spain. Abstract TuPeC4773.
2. Centers for Disease Control and Prevention. U.S. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. MMWR 1998;47(RR-2):1. Updated November 26, 2003.
3. Kourtis AP, Bansil P, McPheeters M, Meikle SF, Posner SF, Jamieson DJ. Hospitalisations of pregnant HIV-infected women in the United States prior to and during the era of highly active antiretroviral therapy: Analysis of the Healthcare Cost and Utilization Project, 1994-2003. AIDS 2006;20:1823.
4. NIS Technical Documentation. Rockville, MD: Agency for Healthcare Research and Quality: 2003. Available at www.hcupus.ahrq.gov/db/nation/nis/ NIS_Introduction_2003_v7.pdf Accessed December 2005.
5. Minkoff H, Ehrlich I, Feldman J, et al. Reproductive health hospitalizations among women with HIV infections. Am J Obstet Gynecol 1998;178:166.
6. Forsyth BW, Davis JA, Freudigman KA, et al. Pregnancy and birth rates among HIV-infected women in the United States: The confounding effects of illicit drug use. AIDS 2002;16:471.
7. Selwyn PA, Schoenbaum EE, Davenny K, et al. Prospective study of HIV infection and pregnancy outcomes in intravenous drug users. JAMA 1989;261:1289.
8. Gebo KA, Fleishman JA, Moore RD, et al. Hospitalizations for metabolic conditions, opportunistic infections, and injection drug use among HIV patients. J Acquir Immune Defic Syndr 2005;40:609.
9. Tuomala RE, Watts DH, Li D, et al. Improved obstetric outcomes and few maternal toxicities are associated with antiretroviral therapy, including highly active antiretroviral therapy during pregnancy. J Acquir Immune Defic Syndr 2005;38:449.
10. Watts DH, Balasubramanian R, Maupin RT Jr, et al. Maternal toxicity and pregnancy complications in HIV-infected women receiving antiretroviral therapy: PACTG 316. Am J Obstet Gynecol 2004;190:506.